Agf Investments LLC Clovis Oncology, Inc. Transaction History

Agf Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$11.63 - $32.67 $2,930 - $8,232	-252 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$29.37 - $49.48 $4,053 - $6,828	138 Added 121.05%	252 $7,000
Q3 2018 Nov 07, 2018	SELL	$29.37 - $49.48 $8,399 - $14,151	-286 Reduced 71.5%	114 $9,000
Q2 2018 Aug 13, 2018	BUY	$42.06 - $62.4 $16,824 - $24,960	400 New	400 $19,000
Q1 2018 May 04, 2018	SELL	$50.12 - $67.72 $22,052 - $29,796	-440 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$57.69 - $84.58 $12,114 - $17,761	210 Added 91.3%	440 $29,000
Q3 2017 Nov 09, 2017	BUY	$67.17 - $84.81 $15,449 - $19,506	230	230 $20,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.